Glucagon-like peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the National Institutes of Health All of Us Cohort
While scientific research directly linking GLP-1 agonists to these dental problems is still emerging and often anecdotal, the correlation observed in clinical settings by dentists is undeniable
The drug is a once-a-week injection that combines two hormones, GLP-1 and GIP, which work in combination to stimulate insulin secretion and reduce appetite
Second, they indicate minimal risk of allergic or hypersensitivity reactions, which can occur when immune responses develop against therapeutic peptides
Herfindahl Hirschman Index (HHI) 17.2
This oxidative damage severely impairs the mitochondria's ability to produce adenosine triphosphate (ATP), the currency of cellular energy